CIK 0001994702 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Kyverna Therapeutics, Inc.
Sign in to watch- Ticker
- KYTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831365441
- Phone
- 5109252492
- Business address
- 5980 HORTON STREET, SUITE 200, EMERYVILLE, CA
- Former names
- Kyverna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-27 | CLARK IAN T Director | Grant or award | +5,093 | 21,727 | ||
| 2026-05-27 | CLARK IAN T Director | Grant or award · Stock Option (right to buy) | +20,582 | 20,582 | ||
| 2026-05-27 | Cohen Fred E Director | Grant or award | +5,093 | 21,727 | ||
| 2026-05-27 | Cohen Fred E Director | Grant or award · Stock Option (right to buy) | +20,582 | 20,582 | ||
| 2026-05-27 | SEIDENBERG BETH C Director | Grant or award | +5,093 | 21,727 | ||
| 2026-05-27 | SEIDENBERG BETH C Director | Grant or award · Stock Option (right to buy) | +20,582 | 20,582 | ||
| 2026-05-27 | Shaw Christi Executive Chairperson | Shares withheld for taxes | −4,194 | $8.59 | $36K | 66,741 |
| 2026-05-27 | Aktar Mert Director | Grant or award | +5,093 | 21,727 | ||
| 2026-05-27 | Aktar Mert Director | Grant or award · Stock Option (right to buy) | +20,582 | 20,582 | ||
| 2026-05-18 | Martini Gregory S. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +325,000 | 325,000 | ||
| 2026-05-04 | Dac Nadia Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2026-03-13 | GEHCHAN NAJI See Remarks | Grant or award | +18,000 | 18,000 | ||
| 2026-03-13 | GEHCHAN NAJI See Remarks | Grant or award · Stock Option (right to buy) | +105,000 | 105,000 | ||
| 2026-03-13 | GRASSO MARC Chief Financial Officer | Grant or award | +10,000 | 10,000 | ||
| 2026-03-13 | GRASSO MARC Chief Financial Officer | Grant or award · Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2026-03-13 | Biddle Warner Weston Chief Executive Officer | Grant or award | +58,000 | 58,000 | ||
| 2026-03-13 | Biddle Warner Weston Chief Executive Officer | Grant or award · Stock Option (right to buy) | +350,000 | 350,000 | ||
| 2026-02-24 | Miller Andrew Craig Director | Grant or award | +11,006 | 11,006 | ||
| 2026-02-24 | Miller Andrew Craig Director | Grant or award · Stock Option (right to buy) | +42,945 | 42,945 | ||
| 2026-02-24 | Emany Sravan Kumar Director | Grant or award | +11,006 | 11,006 |
Page 1 of 5 · 91 trades